Chronic kidney disease (CKD) is characterized by the retention of solutes named uremic toxins, which strongly associate with high morbidity and mortality. Mounting evidence suggests that targeting uremic toxins and/or their pathways may decrease the risk of cardiovascular disease in CKD patients. Dialysis therapies have been developed to improve removal of uremic toxins. Advances in our understanding of uremic retention solutes as well as improvements in dialysis membranes and techniques (HDx, Expanded Hemodialysis) will offer the opportunity to ameliorate clinical symptoms and outcomes, facilitate personalized and targeted dialysis treatment, and improve quality of life, morbidity and mortality.
Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins / P. Ciceri, M. Cozzolino. - In: TOXINS. - ISSN 2072-6651. - 13:6(2021), pp. 380.1-380.14. [10.3390/toxins13060380]
Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins
P. Ciceri;M. Cozzolino
Ultimo
2021
Abstract
Chronic kidney disease (CKD) is characterized by the retention of solutes named uremic toxins, which strongly associate with high morbidity and mortality. Mounting evidence suggests that targeting uremic toxins and/or their pathways may decrease the risk of cardiovascular disease in CKD patients. Dialysis therapies have been developed to improve removal of uremic toxins. Advances in our understanding of uremic retention solutes as well as improvements in dialysis membranes and techniques (HDx, Expanded Hemodialysis) will offer the opportunity to ameliorate clinical symptoms and outcomes, facilitate personalized and targeted dialysis treatment, and improve quality of life, morbidity and mortality.File | Dimensione | Formato | |
---|---|---|---|
toxins-13-00380.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
562.12 kB
Formato
Adobe PDF
|
562.12 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.